Efficacy of perioperative systemic tranexamic acid along with topical hemocoagulase in decreasing axillary drain output in breast cancer patients undergoing axillary lymph node dissection: A randomized, double-blind, placebo-controlled, superiority trial.

Abstract

Excess and prolonged axillary drainage is a frequent nuisance following axillary lymph node dissection (ALND) in breast cancer patients. No consensus exists about the best method to prevent this consistently and reliably. Tranexamic acid (TA) has been found to reduce the amount and duration of drainage, but the reduction is not optimal. We hypothesized that systemic administration of TA along with the topical application of hemocoagulase (H) to the axillary dissection bed may decrease the cumulative axillary drain output and shorten the requirement of drainage after ALND as compared to placebo. Seventy women undergoing ALND for breast carcinoma were randomized into two groups, the intervention (TA+H) group and the control (C) group. The cumulative drain output (primary objective), duration of drainage, incidence of seroma formation after drain removal, number of seroma aspirations required, volume of seroma aspirated, and incidence of surgical site infection (SSI) were compared. The mean cumulative output in the TA+H group was significantly lower than the C group (290±200mL vs. 552±369mL, p<0.001). Axillary drains were removed significantly earlier in the TA+H group (6.6±2.2 vs. 11.7±6.0days, p<0.001), but the incidence of seroma formation (p=0.34), number of aspirations required (p=0.33), volume of seroma aspirated (p=0.47), and the incidence of SSI (p=0.07) were similar. Perioperative systemic administration of tranexamic acid along with topical application of H to the axillary dissection bed is effective in reducing cumulative axillary drain output after ALND. This strategy may also facilitate earlier removal of suction drains.